# Monoclonal Gammopathy of Undetermined Significance and Associated Cardiovascular Outcomes in a Hospital Setting—A Fresh Perspective

**Authors:** Ahmad Mustafa, Chapman Wei, Ghada Araji, Muhammad Rafay Khan Niazi, Radu Grovu, Mitchell Weinberg, James Lafferty

PMC · DOI: 10.3390/curroncol31080331 · Current Oncology · 2024-08-01

## TL;DR

This study explores how monoclonal gammopathy of undetermined significance (MGUS) is linked to various cardiovascular issues in hospitalized patients.

## Contribution

The study provides new insights into the cardiovascular risks of MGUS in a hospital setting using a large national database.

## Key findings

- MGUS patients had higher rates of heart failure, atrial fibrillation, and venous thromboembolism.
- After matching, MGUS was still associated with aortic stenosis, mitral regurgitation, and peripheral vascular disease.
- The study highlights the need for better screening and management of cardiovascular complications in MGUS patients.

## Abstract

There is a paucity of data on the cardiovascular implications of monoclonal gammopathy of undetermined significance, especially among hospitalized patients. Our study aimed to investigate the association between MGUS and cardiovascular outcomes in a hospital setting using the National Inpatient Sample database. MGUS patients were sampled using ICD-10 codes. The patients were stratified into two cohorts based on the presence or absence of MGUS. Comorbidities and cardiovascular outcomes were collected using ICD 10 DM codes. CV outcomes were evaluated before and after 1:1 matching for age, gender, and race. Furthermore, a sensitivity analysis was performed on the matched population, which excluded patients with diabetes mellitus, prior myocardial infarction, chronic kidney disease (stages 3–5), dialysis, hypertension, obesity, metabolic syndrome, cancer, antiplatelets, and oral anticoagulant use and was adjusted for smoking, dyslipidemia, and aspirin use to evaluate the cardiovascular outcomes. MGUS patients had more heart failure, atrial fibrillation, venous thromboembolism, aortic aneurysm, aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, conduction disorder, cor pulmonale, peripheral vascular disease, and acute myocardial infarction. After matching, MGUS was associated with heart failure, atrial fibrillation, venous thromboembolism, aortic stenosis, mitral regurgitation, conduction disorder, cor pulmonale, and peripheral vascular disease. MGUS was linked to a wide spectrum of cardiovascular diseases in an inpatient setting. Further studies are needed to formulate appropriate recommendations for the screening and management of cardiovascular complications in individuals with MGUS.

## Linked entities

- **Diseases:** monoclonal gammopathy of undetermined significance (MONDO:0004225), heart failure (MONDO:0005252), atrial fibrillation (MONDO:0004981), venous thromboembolism (MONDO:0005399), aortic aneurysm (MONDO:0005160), aortic stenosis (MONDO:0042981), mitral stenosis (MONDO:0005852), conduction disorder (MONDO:0100042), cor pulmonale (MONDO:0001493), peripheral vascular disease (MONDO:0005294), acute myocardial infarction (MONDO:0004781), diabetes mellitus (MONDO:0005015), chronic kidney disease (MONDO:0005300), obesity (MONDO:0011122), metabolic syndrome (MONDO:0000816), cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** Monoclonal Gammopathy (MESH:D010265), dyslipidemia (MESH:D050171), mitral regurgitation (MESH:D008944), metabolic syndrome (MESH:D024821), cor pulmonale (MESH:D011660), heart failure (MESH:D006333), chronic kidney disease (MESH:D051436), obesity (MESH:D009765), conduction disorder (MESH:D019955), smoking (MESH:D015208), DM (MESH:D009223), hypertension (MESH:D006973), atrial fibrillation (MESH:D001281), cardiovascular complications (MESH:D002318), aortic regurgitation (MESH:D001022), diabetes mellitus (MESH:D003920), aortic aneurysm (MESH:D001014), acute myocardial infarction (MESH:D009203), peripheral vascular disease (MESH:D016491), mitral stenosis (MESH:D008946), aortic stenosis (MESH:D001024), cancer (MESH:D009369), venous thromboembolism (MESH:D054556)
- **Chemicals:** aspirin (MESH:D001241), antiplatelets (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11352401/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11352401/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC11352401/full.md

---
Source: https://tomesphere.com/paper/PMC11352401